NH THERAGUIX SAS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 EUR | -.--% |
|
-.--% | -.--% |
| Sales 2019 | 972K 1.04M 86.69M | Sales 2020 | 1.32M 1.42M 118M | Capitalization | 113M 121M 10.12B |
|---|---|---|---|---|---|
| Net income 2019 | -2M -2.14M -178M | Net income 2020 | -4M -4.28M -357M | EV / Sales 2019 * | - |
| Net cash position 2019 * | - 0 0 | Net cash position 2020 * | - 0 0 | EV / Sales 2020 * | - |
| P/E ratio 2019 * |
-
| P/E ratio 2020 * |
-
| Employees | 14 |
| Yield 2019 * |
-
| Yield 2020 * |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Vincent Carrère
CEO | Chief Executive Officer | - | - |
Géraldine Le Duc
FOU | Founder | - | 11/15/11 |
Caroline Cayre
DFI | Director of Finance/CFO | - | 01/19/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 22/19/22 | |
Marc Le Bozec
BRD | Director/Board Member | - | 22/19/22 |
| Chairman | 62 | 22/19/22 |
- Stock Market
- Equities
- ALNHT Stock
